Ananda Mirchandani

Medicine & Life Sciences

1. Neutrophils 100%
2. Adult Respiratory Distress Syndrome 62%
3. Hypoxia 56%
4. Prolyl Hydroxylases 43%
5. Lung Injury 39%
6. Inflammation 39%
7. Coronavirus 37%
8. Acute Lung Injury 35%
9. Early Growth Response Protein 2 28%
10. Glycogen 27%
11. Macrophages 23%
12. Semaphorins 21%
13. Gluconeogenesis 18%
14. Th2 Cells 17%
15. Pseudomonas 16%
16. Alveolar Macrophages 16%
17. Carbon 14%
18. Oxygen 14%
19. Bacterial Infections 13%
20. Monocytes 13%
21. Leukocytes 11%
22. Interferon Type I 11%
23. Pneumonia 11%
24. Endotoxins 11%
25. Lymphocytes 10%
26. Streptococcus pneumoniae 8%
27. Glycolysis 8%
28. Interleukin-4 8%
29. Lung 8%
30. In Vitro Techniques 8%
31. Granulocyte-Macrophage Colony-Stimulating Factor 7%
32. Cytokines 7%
33. Neutrophil Activation 7%
34. Phenotype 7%
35. Health 7%
36. Sepsis 7%
37. Infections 6%
38. Mixed Function Oxygenases 6%
39. Up-Regulation 6%
40. T-Lymphocytes 6%
41. Mortality 6%
42. Proteins 6%
43. Severe Acute Respiratory Syndrome 5%
44. human MIRN210 microRNA 5%
45. Innate Immunity 5%
46. sulofenur 5%
47. Wounds and Injuries 5%
48. Altitude Sickness 5%
49. Metabolic Networks and Pathways 5%
50. Antigen Presentation 5%